Skip to main content
SpringerLink
Log in

HUNTINGTON’S DISEASE

A small molecule kicks repeat expansion into reverse

  • News & Views
  • Published:

From Nature Genetics

View current issue Submit your manuscript

Huntington’s disease is a severe progressive neurological disorder caused by a CAG-repeat expansion in the HTT gene. A small molecule shows therapeutic potential by inducing contraction of these expanded CAG repeats in cell and mouse models of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: NA induces contraction of CAG repeats in a mouse model of HD.

References

  1. Neil, A. J., Kim, J. C. & Mirkin, S. M. BioEssays 39, 1700077 (2017).

    Article  Google Scholar 

  2. Kennedy, L. et al. Hum. Mol. Genet. 12, 3359–3367 (2003).

    Article  CAS  Google Scholar 

  3. Thornton, C. A., Johnson, K. & Moxley, R. T. III Ann. Neurol. 35, 104–107 (1994).

    Article  CAS  Google Scholar 

  4. Ciosi, M. et al. EBioMedicine 48, 568–580 (2019).

    Article  Google Scholar 

  5. Pinto, R. M. et al. PLoS Genet. 9, e1003930 (2013).

    Article  Google Scholar 

  6. Dragileva, E. et al. Neurobiol. Dis. 33, 37–47 (2009).

    Article  CAS  Google Scholar 

  7. Tomé, S. et al. PLoS Genet. 9, e1003280 (2013).

    Article  Google Scholar 

  8. Nakatani, R., Nakamori, M., Fujimura, H., Mochizuki, H. & Takahashi, M. P. Sci. Rep. 5, 11020 (2015).

    Article  CAS  Google Scholar 

  9. Bourn, R. L. et al. PLoS One 7, e47085 (2012).

    Article  CAS  Google Scholar 

  10. Zhao, X. N. et al. Hum. Mol. Genet. 24, 7087–7096 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. Cell 162, 516–526 (2015).

    Article  Google Scholar 

  12. Lee, J. M. et al. Hum. Mol. Genet. 26, 3859–3867 (2017).

    Article  CAS  Google Scholar 

  13. Moss, D. J. H. et al. Lancet Neurol. 16, 701–711 (2017).

    Article  CAS  Google Scholar 

  14. Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium. CAG repeat not polyglutamine length determines timing of Huntington’s Disease onset. Cell 178, 887–900.e14.

  15. Bettencourt, C. et al. Ann. Neurol. 79, 983–990 (2016).

    Article  CAS  Google Scholar 

  16. Nakamori, M. et al. Nat. Genet. https://doi.org/10.1038/s41588-019-0575-8 (2020).

  17. Hagihara, M. & Nakatani, K. Nucleic Acids Symp. Ser. (Oxf.) 50, 147–148 (2006).

    Article  Google Scholar 

  18. Axford, M. M. et al. PLoS Genet. 9, e1003866 (2013).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University College London (UCL) Huntington’s Disease Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology and Dementia Research Centre at UCL, London, UK

    Michael D. Flower & Sarah J. Tabrizi

Authors
  1. Michael D. Flower
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah J. Tabrizi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarah J. Tabrizi.

Ethics declarations

Competing interests

M.D.F. has no competing interests. S.J.T. is on scientific advisory boards for Triplet Therapeutics and LoQus therapeutics and has laboratory funding from Vertex pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Flower, M.D., Tabrizi, S.J. A small molecule kicks repeat expansion into reverse. Nat Genet 52, 136–137 (2020). https://doi.org/10.1038/s41588-020-0577-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41588-020-0577-6

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation